Physician profile
Nathan L Compton
NPI 1316110745
$4,722.80
in general payments reported to CMS, 2019-2025
40 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,426 · 2020: $436 · 2021: $269 · 2022: $197 · 2023: $522 · 2024: $396 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,241.25 | 2019-2022 | |
| Davol INC. | $452.34 | 2020-2025 | Phasix Mesh |
| Janssen Biotech, INC. | $319.79 | 2022-2025 | Erleada |
| Allergan, INC. | $193.33 | 2019-2022 | |
| Abbvie INC. | $188.40 | 2019-2024 | Strattice Reconstructive Tissue Matrix Bps, Lupron Depot |
| Bayer Healthcare Pharmaceuticals INC. | $155.99 | 2019-2025 | |
| Ethicon US, LLC | $138.83 | 2019-2024 | Echelon Flex, Certus 140 |
| Tela Bio, INC. | $98.85 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Coloplast Corp | $95.55 | 2020-2025 | Titan |
| Tolmar, INC. | $82.12 | 2023-2025 | Eligard, Jatenzo |
| Sumitomo Pharma America, INC. | $79.11 | 2023-2024 | Gemtesa |
| Acera Surgical, INC. | $40.83 | 2024 | Restrata Wound Matrix |
| Dendreon Pharmaceuticals LLC | $36.66 | 2019 | |
| Urogen Pharma, INC. | $35.06 | 2021-2022 | |
| Teleflex LLC | $35.00 | 2020-2025 | Urolift |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.